Effect of changing antiretroviral treatment eligibility criteria on patient load in Kampala, Uganda

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 23, Issue 1, 2011, Pages 35-41

  Konde Lule, Joseph ^a   Makumbi, Fred ^a   Pakker, Nadine ^b   Muyinda, Asad ^a   Mubiru, Mesach ^c   Cobelens, Frank G J ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^c Kampala City Council   (Uganda)

Author keywords

Africa; eligibility criteria; HIV antiretroviral therapy; Uganda

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE TRANSMISSION; FAMILY PLANNING; FEMALE; HEALTH CARE QUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PATIENT COUNSELING; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUANTITATIVE ANALYSIS; SURVIVAL; UGANDA; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; ELIGIBILITY DETERMINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; NEEDS ASSESSMENT; PREVALENCE; PRIMARY HEALTH CARE; UGANDA; YOUNG ADULT;

EID: 78651365966     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2010.498869     Document Type: Article

References (20)

1. Auvert B. Males S. Puren A. Taljaard D. Carael M. & Williams B. 2004. Can highly active antiretroviral therapy reduce the spread of HIV? A study in a township of South Africa. Journal of Acquired Immune Deficiency Syndromes 361 613-621.
2. Baker J.V. Peng G. Rapkin J. Abrams D.I. Silverberg M.J. MacArthur R.D. Terry Beirn Community Programs for Clinical Research on AIDS CPCRA. 2008. CD4- count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 227 841-848.
3. Chow K.Y. And L.W. Verghesse I. Chwe S.K. & Leo Y.S. 2005. Measurable predictive factors for progression to AIDS among HIV infected patients in Singapore. Annals Academy of Medicine Singapore 34 84-89.
4. De Cock K.M. Crowley S.P. Lo Y-R. Granich R.M. & Williams B.G. 2009. Preventing HIV transmission with antiretrovirals. Bulletin of the World Health Organization 87 488-488A. doi: 10.2471/BLT.09.067 330
5. Edmonds A. Lusiama J. Napravnik S. Kitetele F. Van Rie A. & Behets F. 2009. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. International Journal of Epidemiology 386 1612- 1621.
6. Garcia-Calleja J.M. Gouws E. & Ghys P.D. 2006. National population based HIV prevalence surveys in sub-Saharan Africa: Results and implications for HIV and AIDS estimates. Sexually Transmitted Infections 82Suppl. 3 iii64-iii70.
7. Hammer S.M. Eron Jr. J.J. Reiss P. Schooley R.T. Thompson M.A. Walmsley S. Volberding P.A. 2008. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society- USA panel. JAMA 3005 555-570.
8. Kigozi I.M. Dobkin L.M. Martin J.N. Geng E.H. Muyindike W. Emenyonu N.I. Hahn J.A. 2009. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub- Saharan Africa. Journal of Acquired Immune Deficiency Syndromes 522 280-289.
9. Kishamawe C. Vissers D.C. Urassa M. Isingo R. Mwaluko G. Borsboom G.J. de Vlas S.J. 2006. Mobility and HIV in Tanzanian couples: Both mobile persons and their partners show increased risk. AIDS 204 601-608.
10. Kitahata M.M. Gange S.J. Abraham A.G. Merriman B. Saag M.S. Justice A.C. Moore R.D. 2009. Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine 36018 1815-1826.
11. Lydie N. Robinson N.J. Ferry B. Akam E. De Loenzien M. & Abega S. 2004. Mobility sexual behavior and HIV infection in an urban population in Cameroon. Journal of Acquired Immune Deficiency Syndromes 351 67-74.
12. Macro U.M.o.H. 2006. Uganda HIV/AIDS Sero-behavioral Survey 2004-2005. Claverton MD: Ministry of Health in Uganda Kampala Uganda and ORC Macro.
13. Patel K. Hernan M.A. Williams P.L. Seeger J.D. McIntosh K. Van Dyke R.B. & Seage III G.R. 2008. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: A 10-year follow-up study. Clinical Infectious Diseases 464 507-515. (Pubitemid 351263487)
14. Pezzotti P. Phillips A.N. Dorrucci M. Lepri A.C. Galai N. Vlahov D. & Rezza G. 1996. Category of exposure to HIV and age in the progression to AIDS: Longitudinal study of 1199 people with known dates of seroconversion. BMJ 313 583-586.
15. Statistics U.B.o. 2002. The 2002 Uganda population and housing census population size and distribution. Entebbe Uganda: National census office Uganda Bureau of Statistics.
16. Uganda M.o.H. 2003. National antiretroviral treatmentand care guidelines for adults and children 1st ed.. Kampala Uganda: Ministry of Health in Uganda.
17. Uganda M.o.H. 2008. National antiretroviral treatment and care guidelines for adults and children 2nd ed.. Kampala Uganda: Ministry of Health in Uganda.
18. UNAIDS 2008. Report on global AIDS epidemic. Geneva Switzerland: WHO/UNAIDS.
19. Walensky R.P. Paltiel A.D. Losina E. Mercincavage L.M. Schackman B.R. Sax P.E. Freedberg K.A. 2006. The survival benefits of AIDS treatment in the United States. Journal of Infectious Diseases 1941 11-19.
20. Zou G. 2004. A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 1597 702-706.